TB Reach Wave 11 — Health Camps & Facility Screening
BCHPR · Stop TB Partnership · Apr 2025 – present
Largest and most operationally complex BCHPR data system — 19,673 lines integrating 5 REDCap projects across community health camps, primary health facility screening, and prison screening in 7 regions of Cameroon. Target: 494,400 screenings and 105,646 diagnostic results.
Highlights
- 5 integrated REDCap projects (Health Camps · Location · Primary Health Screening · Primary Health Results · Daily Attendance).
- Dual QR-code schemes — screening QR for participant ID and testing QR for specimen ID — enable flexible post-collection linkage.
- Spirometry PDF extractor (1,743 lines) using pdfplumber with French / English / hybrid detection, SHA-256 deduplication, and SQLite file-hash index.
- Windows COM Outlook email processor that auto-ingests monthly site reports from regional coordinators with MMM-YYYY regex.
- Multi-language spirometry parameter mapping (French CVF → FVC, VEMS → FEV1, DEF25-75 → FEF25-75).
- Three-stage Airflow orchestration: Pipeline (hourly 6am–6pm) · User Activity (30 min incremental) · Reports (3-hourly).
- Cross-project linkage with Global Outcome treatment tracking and FujiLAM II eligibility via FC IDs.
Related projects
Country Data Manager
Start4All — Cameroon Country Data Management
End-to-end Cameroon data operations for Start4All — a 7-country TB intervention programme evaluating near-POC molecular diagnostics and sputum pooling. Evidence fed the WHO 9 March 2026 recommendations; LSTM's 27 February 2026 commentary explicitly cited Start4All.
Data Manager
TB Reach Wave 10 Cameroon — Data Management
Cameroon TB Reach Wave 10 data backbone — community-based active case finding using chest X-ray AI triage paired with sputum pooling for molecular confirmation.
Lead Data Manager
GHIT FujiLAM II — Multi-Country Diagnostic Accuracy Study
21,036-line data platform for a diagnostic accuracy study evaluating FujiLAM, Alere LAM, GeneXpert, and molecular tests across 12 sites in Cameroon and Nigeria — supporting WHO prequalification evidence for next-generation TB diagnostics.